These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 28691657)
1. A relevant in vitro human model for the study of Zika virus antibody-dependent enhancement. Londono-Renteria B; Troupin A; Cardenas JC; Hall A; Perez OG; Cardenas L; Hartstone-Rose A; Halstead SB; Colpitts TM J Gen Virol; 2017 Jul; 98(7):1702-1712. PubMed ID: 28691657 [TBL] [Abstract][Full Text] [Related]
2. Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection. Khandia R; Munjal A; Dhama K; Karthik K; Tiwari R; Malik YS; Singh RK; Chaicumpa W Front Immunol; 2018; 9():597. PubMed ID: 29740424 [TBL] [Abstract][Full Text] [Related]
5. Quantification of Antibody-dependent Enhancement of the Zika Virus in Primary Human Cells. Asad S; Feitosa-Suntheimer F; Gold A; Londono-Renteria B; Colpitts TM J Vis Exp; 2019 Jan; (143):. PubMed ID: 30735189 [TBL] [Abstract][Full Text] [Related]
6. Dengue immune sera enhance Zika virus infection in human peripheral blood monocytes through Fc gamma receptors. Li M; Zhao L; Zhang C; Wang X; Hong W; Sun J; Liu R; Yu L; Wang J; Zhang F; Jin X PLoS One; 2018; 13(7):e0200478. PubMed ID: 30044839 [TBL] [Abstract][Full Text] [Related]
7. Dengue Virus and Zika Virus Serological Cross-reactivity and Their Impact on Pathogenesis in Mice. Watanabe S; Tan NWW; Chan KWK; Vasudevan SG J Infect Dis; 2019 Jan; 219(2):223-233. PubMed ID: 30085051 [TBL] [Abstract][Full Text] [Related]
8. The possible role of cross-reactive dengue virus antibodies in Zika virus pathogenesis. Langerak T; Mumtaz N; Tolk VI; van Gorp ECM; Martina BE; Rockx B; Koopmans MPG PLoS Pathog; 2019 Apr; 15(4):e1007640. PubMed ID: 30998804 [TBL] [Abstract][Full Text] [Related]
9. Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas. Montoya M; Collins M; Dejnirattisai W; Katzelnick LC; Puerta-Guardo H; Jadi R; Schildhauer S; Supasa P; Vasanawathana S; Malasit P; Mongkolsapaya J; de Silva AD; Tissera H; Balmaseda A; Screaton G; de Silva AM; Harris E J Infect Dis; 2018 Jul; 218(4):536-545. PubMed ID: 29618091 [TBL] [Abstract][Full Text] [Related]
16. Humoral cross-reactivity between Zika and dengue viruses: implications for protection and pathology. Priyamvada L; Hudson W; Ahmed R; Wrammert J Emerg Microbes Infect; 2017 May; 6(5):e33. PubMed ID: 28487557 [TBL] [Abstract][Full Text] [Related]
17. ELISPOT-Based "Multi-Color FluoroSpot" to Study Type-Specific and Cross-Reactive Responses in Memory B Cells after Dengue and Zika Virus Infections. Andrade P; Coloma J; Harris E Methods Mol Biol; 2018; 1808():151-163. PubMed ID: 29956181 [TBL] [Abstract][Full Text] [Related]
18. Pre-existing T Cell Memory against Zika Virus. Schouest B; Grifoni A; Pham J; Mateus J; Sydney J; Brien JD; De Silva AD; Balmaseda A; Harris E; Sette A; Weiskopf D J Virol; 2021 May; 95(12):. PubMed ID: 33789994 [TBL] [Abstract][Full Text] [Related]
19. Human antibody response to Zika targets type-specific quaternary structure epitopes. Collins MH; Tu HA; Gimblet-Ochieng C; Liou GA; Jadi RS; Metz SW; Thomas A; McElvany BD; Davidson E; Doranz BJ; Reyes Y; Bowman NM; Becker-Dreps S; Bucardo F; Lazear HM; Diehl SA; de Silva AM JCI Insight; 2019 Apr; 4(8):. PubMed ID: 30996133 [TBL] [Abstract][Full Text] [Related]
20. Viral Load and Cytokine Response Profile Does Not Support Antibody-Dependent Enhancement in Dengue-Primed Zika Virus-Infected Patients. Terzian ACB; Schanoski AS; Mota MTO; da Silva RA; Estofolete CF; Colombo TE; Rahal P; Hanley KA; Vasilakis N; Kalil J; Nogueira ML Clin Infect Dis; 2017 Oct; 65(8):1260-1265. PubMed ID: 29017246 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]